- increased circulating creatinine level / IMPC
- decreased circulating cholesterol level / IMPC
- decreased circulating total protein level / IMPC
- decreased circulating serum albumin level / IMPC
- decreased circulating glucose level / IMPC
- increased mean corpuscular volume / IMPC
- decreased total retina thickness / IMPC
- short tibia / IMPC
- decreased exploration in new environment / IMPC
- decreased circulating HDL cholesterol level / IMPC
- decreased erythrocyte cell number / IMPC
C57BL/6NTac-Pgam5tm1a(EUCOMM)Wtsi/IcsOrl
Status | Available to order |
EMMA ID | EM:09258 |
Citation information | RRID:IMSR_EM:09258 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | C57BL/6NTac-Pgam5tm1a(EUCOMM)Wtsi/IcsOrl |
Alternative name | EPD0226_5_A02 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Pgam5tm1a(EUCOMM)Wtsi |
Gene/Transgene symbol | Pgam5 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | ICS, Institut Clinique de la Souris |
Provider affiliation | ICS, Institut Clinique de la Souris |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0226_5_A02. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Institut de Transgenose, INTRAGENE, Orléans, France |
Animals used for archiving | heterozygous C57BL/6NTac males |
Disease and phenotype information
IMPC phenotypes (gene matching)
MGI phenotypes (allele matching)
- abnormal gait / MGI
- short stride length / MGI
- abnormal motor coordination/ balance / MGI
- akinesia / MGI
- decreased vertical activity / MGI
- no phenotypic analysis / MGI
- neuron degeneration / MGI
- loss of dopaminergic neurons / MGI
- oxidative stress / MGI
- bradykinesia / MGI
- homeostasis/metabolism phenotype / MGI
- decreased dopamine level / MGI
- abnormal mitochondrion morphology / MGI
- abnormal mitochondrial physiology / MGI
- abnormal mitochondrial crista morphology / MGI
MGI phenotypes (gene matching)
- decreased body weight / MGI
- decreased body size / MGI
- abnormal gait / MGI
- short stride length / MGI
- abnormal motor coordination/balance / MGI
- premature death / MGI
- no abnormal phenotype detected / MGI
- akinesia / MGI
- decreased vertical activity / MGI
- no phenotypic analysis / MGI
- abnormal redox activity / MGI
- neuron degeneration / MGI
- loss of dopaminergic neurons / MGI
- oxidative stress / MGI
- bradykinesia / MGI
- homeostasis/metabolism phenotype / MGI
- cellular phenotype / MGI
- decreased dopamine level / MGI
- abnormal mitochondrion morphology / MGI
- abnormal mitochondrial physiology / MGI
- abnormal interleukin-1 beta secretion / MGI
- decreased interleukin-1 beta secretion / MGI
- decreased survivor rate / MGI
- abnormal macrophage activation involved in immune response / MGI
- prenatal lethality, incomplete penetrance / MGI
- abnormal mitochondrial shape / MGI
- abnormal mitochondrial crista morphology / MGI